|
1 Nanotechnology and Its Drug Delivery Applications |
|
|
1 | (32) |
|
|
1 | (1) |
|
1.2 Historical Prospects of Nanotechnology |
|
|
2 | (1) |
|
1.3 Promising Role in Drug Delivery |
|
|
3 | (11) |
|
1.3.1 Nanoparticles and Drug Delivery |
|
|
8 | (1) |
|
1.3.2 Use of NPs Formulation in Drug Delivery |
|
|
9 | (2) |
|
1.3.3 Cellular and Intracellular Targets |
|
|
11 | (1) |
|
1.3.4 The Brain---The Ultimate Target for Drug Delivery |
|
|
12 | (2) |
|
1.4 Innovations in Nanotechnology |
|
|
14 | (2) |
|
1.5 Nanotechnology Theory to Applications |
|
|
16 | (3) |
|
1.6 Nanomedicine/Nanoscience/Nano-Engineering and Relationship with Drug Delivery |
|
|
19 | (4) |
|
1.6.1 Nanomedicine and Drug Delivery |
|
|
19 | (2) |
|
1.6.2 Nanoengineering and Drug Delivery |
|
|
21 | (2) |
|
1.7 Types of Nanodelivery: Natural or Synthetic |
|
|
23 | (1) |
|
|
23 | (1) |
|
|
23 | (1) |
|
1.8 Natural and Synthetic Polymeric Nanoparticles |
|
|
24 | (9) |
|
2 Nanoparticles Types, Classification, Characterization, Fabrication Methods and Drug Delivery Applications |
|
|
33 | (62) |
|
|
34 | (6) |
|
2.2 Classification of Nanoparticles |
|
|
40 | (1) |
|
2.3 Characterization of Nanoparticles |
|
|
40 | (4) |
|
|
40 | (3) |
|
|
43 | (1) |
|
2.3.3 Surface Hydrophobicity |
|
|
44 | (1) |
|
|
44 | (1) |
|
2.4 Preparation of Nanoparticles |
|
|
44 | (6) |
|
2.4.1 Solvent Evaporation Method |
|
|
45 | (1) |
|
2.4.2 Spontaneous Emulsification or Solvent Diffusion Method |
|
|
46 | (1) |
|
2.4.3 Double Emulsion and Evaporation Method |
|
|
46 | (1) |
|
|
46 | (1) |
|
2.4.5 Emulsions-Diffusion Method |
|
|
47 | (1) |
|
2.4.6 Solvent Displacement/Precipitation Method |
|
|
48 | (1) |
|
2.4.7 Coacervation or Ionic Gelation Method |
|
|
48 | (1) |
|
2.4.8 Polymerization Method |
|
|
49 | (1) |
|
2.4.9 Production of Nanoparticles Using Supercritical Fluid Technology |
|
|
49 | (1) |
|
2.5 Most Favorable Requirements for Designing Therapeutic Nanoparticles |
|
|
50 | (1) |
|
2.6 Types of Pharmaceutical Nanosystems |
|
|
51 | (33) |
|
2.6.1 Carbon Based Structures |
|
|
51 | (2) |
|
|
53 | (1) |
|
|
54 | (2) |
|
|
56 | (1) |
|
|
57 | (1) |
|
2.6.6 Paramagnetic Nanoparticles |
|
|
58 | (1) |
|
|
59 | (1) |
|
|
59 | (1) |
|
|
60 | (4) |
|
|
64 | (1) |
|
|
64 | (1) |
|
2.6.12 Nanocrystals and Nanosuspension |
|
|
65 | (1) |
|
2.6.13 Solid Lipid Nanoparticles |
|
|
65 | (1) |
|
2.6.14 Silicon-Based Structures |
|
|
66 | (1) |
|
2.6.15 Metallic Nanoparticles |
|
|
67 | (1) |
|
|
67 | (1) |
|
2.6.17 Polymeric Micelles |
|
|
68 | (1) |
|
2.6.18 Polymer Drug Conjugate |
|
|
69 | (1) |
|
2.6.19 Polyplexes/Lipopolyplexes |
|
|
69 | (1) |
|
|
69 | (1) |
|
2.6.21 Polymeric Nanoparticles |
|
|
70 | (2) |
|
2.6.22 Applications of Nanoparticulate Delivery Systems |
|
|
72 | (1) |
|
|
73 | (1) |
|
|
73 | (2) |
|
2.6.25 Tumor Targeting Using Nanoparticulate Delivery Systems |
|
|
75 | (1) |
|
2.6.26 Long-Circulating and Target-Specific Nanoparticles |
|
|
76 | (2) |
|
2.6.27 Nanoparticles for Oral Delivery of Peptides and Proteins |
|
|
78 | (1) |
|
2.6.28 Nanoparticles for Gene Delivery |
|
|
79 | (1) |
|
2.6.29 Nanoparticles for Drug Delivery into the Brain |
|
|
80 | (1) |
|
2.6.30 Anthrax Vaccine Uses Nanoparticles to Produce Immunity |
|
|
81 | (1) |
|
|
81 | (1) |
|
2.6.32 Gold Nanoparticles Detect Cancer |
|
|
82 | (2) |
|
2.7 Hazards and Toxicity Profile of Nanoparticles |
|
|
84 | (11) |
|
2.7.1 Health Implication of Nanoparticles |
|
|
84 | (11) |
|
3 Natural Polymers vs Synthetic Polymer |
|
|
95 | (24) |
|
3.1 Bioengineered Materials: Nano-Engines of Drug Delivery Systems |
|
|
95 | (1) |
|
3.2 Polymeric Nanoparticles |
|
|
96 | (1) |
|
3.3 Contemporary Methodologies for Fabrication of Polymeric Nanoparticles |
|
|
97 | (1) |
|
3.4 Activation-Modulated Drug Delivery: Environmental Activation/Stimuli Responsive Smart Delivery System |
|
|
98 | (2) |
|
3.5 Time to Move on Innovative Methods of Administration |
|
|
100 | (2) |
|
3.6 History of Drug Delivery from the Ancient to Date |
|
|
102 | (4) |
|
3.6.1 Historical Role of Polymers as Plastics |
|
|
105 | (1) |
|
3.7 Shift from Nature to Synthetic (Including the Merits and Demerits of Synthetic Polymers) |
|
|
106 | (8) |
|
3.7.1 Natural Polymers and Synthetic Polymers for Scaffolds |
|
|
109 | (1) |
|
3.7.2 Natural vs Synthetic Polymer (as Biomaterial) |
|
|
110 | (2) |
|
3.7.3 Natural vs Synthetic Polymer in Tissue Engineering |
|
|
112 | (1) |
|
3.7.4 Natural vs Synthetic Polymer Hydrogels |
|
|
113 | (1) |
|
3.8 Natural Polymers (Reasons for Reverting to Nature) |
|
|
114 | (5) |
|
3.8.1 Need of Natural Polymers |
|
|
115 | (1) |
|
3.8.2 Disadvantages of Herbal Polymers |
|
|
116 | (3) |
|
4 Plant Derived Polymers, Properties, Modification & Applications |
|
|
119 | (66) |
|
|
119 | (2) |
|
4.2 Sources of Plant Polymers |
|
|
121 | (3) |
|
4.3 Methods of Extractions |
|
|
124 | (2) |
|
|
124 | (1) |
|
4.3.2 Hot Extraction [ Mild Acidic (EHA), Alkaline (EHB) and Radical Hydrolysis (EHR)] |
|
|
125 | (1) |
|
4.3.3 Radical Hydrolysis (EHR) |
|
|
125 | (1) |
|
4.3.4 Microwave Assisted Extraction (EM) |
|
|
125 | (1) |
|
4.3.5 Ultrasonic Extraction (EU) |
|
|
126 | (1) |
|
4.3.6 Enzymatic Hydrolysis (EE) |
|
|
126 | (1) |
|
4.4 Chemical Composition Analysis |
|
|
126 | (1) |
|
|
126 | (1) |
|
4.5.1 Determination of Gelling Strength (GS) |
|
|
126 | (1) |
|
4.5.2 Determination of Gelling Temperature (GT) and Melting Temperature (MT) |
|
|
126 | (1) |
|
4.5.3 Viscosity Measurement (VS) |
|
|
127 | (1) |
|
4.5.4 Molecular Mass Determination (MM) |
|
|
127 | (1) |
|
4.6 Physical-Chemical Modification of Plant Based Natural Polymers (PBNPS) |
|
|
127 | (16) |
|
4.6.1 Chemical Modifications of Plant Based Natural Polymers (PBNPS) |
|
|
128 | (6) |
|
4.6.2 Procedure for the Development of Microfibrillated Plant Based Polymers (MPBPS) by Physical Modification |
|
|
134 | (4) |
|
|
138 | (1) |
|
|
139 | (1) |
|
|
140 | (2) |
|
|
142 | (1) |
|
4.7 Genetic/Biotechnology Modification |
|
|
143 | (1) |
|
4.8 Applications of Plant Based Polysaccharides |
|
|
144 | (41) |
|
|
144 | (8) |
|
|
152 | (1) |
|
|
153 | (1) |
|
|
154 | (1) |
|
|
155 | (1) |
|
|
156 | (1) |
|
|
157 | (28) |
|
5 Marine Polysaccharides Based Nano-Materials and Its Applications |
|
|
185 | |
|
|
185 | (1) |
|
5.2 Polysaccharides Derived from Marine Sources |
|
|
186 | (9) |
|
5.2.1 Marine Algae Based Polysaccharides |
|
|
192 | (2) |
|
5.2.2 Marine Crustaceans Derived Polysaccharides |
|
|
194 | (1) |
|
5.3 Nanomaterials Derived from Marine Sources |
|
|
195 | (15) |
|
5.3.1 Nano Scaffolds Derived from Fucoidan |
|
|
195 | (2) |
|
5.3.2 Alginate Nanoparticles |
|
|
197 | (2) |
|
5.3.3 Carrageenan Based Nanoparticles |
|
|
199 | (3) |
|
5.3.4 Agarose Nanoparticles |
|
|
202 | (1) |
|
5.3.5 Porphyran Based Nanoparticles |
|
|
203 | (2) |
|
5.3.6 Nanofibers of Ulvan |
|
|
205 | (1) |
|
5.3.7 Mauran Based Nanoparticles |
|
|
205 | (1) |
|
5.3.8 Chitin and Its Nanoparticles |
|
|
206 | (1) |
|
5.3.9 Chitosan Based Nanoparticles |
|
|
206 | (4) |
|
5.3.10 Chitooligosaccharide Based Nanoparticles |
|
|
210 | (1) |
|
5.4 Marine Polysaccharide-Based Nanomaterials and Its Biomedical and Biotechnological Applications |
|
|
210 | (5) |
|
5.4.1 Biomedical Applications of Marine Polysaccharides |
|
|
211 | (3) |
|
5.4.2 Role of Marine Based Polysaccharides for Biotechnological Applications |
|
|
214 | (1) |
|
5.5 Marine Polysaccharide-Based Nanomaterials and Its Patents |
|
|
215 | |